This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Healthy Volunteers

A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adults

Sponsored by Takeda

About this trial

Last updated 2 months ago

Study ID

TAK-881-1003

Status

Recruiting

Type

Interventional

Phase

Phase 1

Placebo

No

Accepting

18-75 Years
18 to 50 Years
All
All

Trial Timing

Started 3 months ago

What is this trial about?

The main aim of this study is to check how well healthy adults can tolerate TAK-881 with different dosing schedules. During the study, participants will receive one infusion of TAK-881 under the skin (subcutaneous [SC] infusion) on Day 1 at a lower dose level followed by participants receiving multiple infusion of higher dose levels. Participants will be in the study for approximately 19 weeks including screening period and follow-up (End of Treatment [EOT]).

What are the participation requirements?

Yes

Inclusion Criteria

Men and women between 18 and 50 years can participate.
Must be a non-smoker, with no use of nicotine or tobacco products.
Must have Body Mass Index (BMI) between 18.0 and 30.0 kilograms per square meter (kg/m^2).
Must be medically healthy.
No

Exclusion Criteria

Cannot have any current or past medical history of blood, liver, lung, heart, kidney, immune, or brain or psychiatric condition.
Cannot have a history of alcohol or drug abuse within 2 years before dosing.

Additional entry criteria will be discussed with the study doctor.

Locations

Location

Status

Recruiting

For more information, view the full study details:

NCT06935266